May 22, 2015. Rachel s Remedies, LLC Mrs. Rachel E. Jackson 2316 Delaware Ave. #174 Buffalo, New York 14216



Similar documents
October 28, Cavex Holland Bv Mr. Richard Woortman Manager Technical Services Fustweg 5 Haarlem, 2031CJ The NETHERLANDS

May 7, Tactile Systems Technology Inc Daniel Chase V.P. Engineering & Operations 1331 Tyler St NE Minneapolis, Minnesota 55413

February 5, Dear Kristin Pabst,

July 24, Dear Ms. Rhodes:

February 22, Life Spine, Incorporated Mr. Randy Lewis General Manager 2401 West Hassell Road, Suite 1535 Hoffman Estates, Illinois 60169

Phoenix Thera-Lase Systems, LLC Ms. Diane Rutherford Ken Block Consulting 1201 Richardson Drive, Suite 280 Richardson, Texas 75080

Q(K SVJM~jPagelIof 3

May 5, Dear Mr. Courtney:

January 12, Dear Amy Yang:

August 12, Oertli Instrumente AG Ms. Karin Rohr Head of Quality Management & Regulatory Affairs Hafnerwisenstrasse 4 CH 9442 Berneck Switzerland

March 3, Dear Ms. Alice Gong,

April 3, Dear Autumn Liu,

November 20, Vascular Flow Technologies Ltd. Edwin Lindsay VP of QA/RA Prospect Business Centre, Gemini Cresent Dundee DD2 1TY United Kingdom

GE Healthcare MAR

University of Texas Medical School at Houston. April 14, 2015

(k)Suminary k

August 21, TCM Associates Ltd Mr. Iain Alligan Technical Director 3 Hillgrove Business Park Nazeing Road Essex EN9 2HB United Kingdom

DICOM Grid, Inc. January 25, Senior Consultant Biologics Consulting Group, Inc. 400 N. Washington Street, Suite 100 ALEXANDRIA VA 22314

Brainreader ApS February 4, 2015 C/O Mette Munch QA Consultant Skagenvej 21 Egaa, 8250 DENMARK

March 20, Dear Mr. Chen:

510(K) SUMMARY [as required by section (c)] FLIGHT 60 Ventilator 510(k) Number K IaO?2Z, JUL

Ad-tech Medical Instrument Corporation. Principal Consultant Quality & Regulatory Associates, LLC. 800 Levanger Lane. Stoughton, Wisconsin 53589

June 9, Stryker Corporation Garry T. Hayeck, Ph.D. Senior Regulatory Affairs Specialist 2 Pearl Court Allendale, New Jersey 07401

November 17, Nanova Biomaterials, Inc. Mr. Andrew Ritts Senior Research Scientist 3806 Mojave Ct Columbia, Missouri, 65202

510(k) Summary. Dentsply Implants. April 30, 2013

Simpler Implant Solutions Inc Arbutus St. Vancouver, BC V6i 3Y9. haroldbergmanl~ogmail.com Telephone Fax K080115

April 7, Acclarent, Inc. Mr. James Patrick Garvey II Sr. Manager, Regulatory Affairs 1525-B O'Brien Drive Menlo Park, CA 94025

Lewis Ward L.W. Ward and Associates, Inc Kirkwood Court Boulder, CO

I~r it NOV SIE T AENCORE Tongue Suspension System OCE L_ August 3, (k) Summary. Appendix 3:

September 25, Dear Ms. McCoy:

kok1 UQ 510(k)J Device {Applicant 510(k) Summary (per 21 CFR (c)) OCT Applicant

0 EC V-,) 133 Lj9a

(k) SUMMARY DEC

October 29, Dear Ms. Hartnett:

FEB Mr. Gordon J. Peters Director Regulatory Compliance DocuSys, Incorporated 820 S. University Boulevard, Suite 3-H Mobile, Alabama 36609

2. Contact Person: Garo Mimaryan, MS., RAC 7 Technical Regulatory Affairs Specialist III 3. Phone Number: (914)

Section 5-510(k) Summary. This document is provided in the following pages. DEC

510(k) Summary. Atlanti STM Abutment and AtlantisTM Crown Abutment in Zirconia for Dentsply Ankylos Implant

BMR ~131o-lvleccai Kesearcn Ltd.

Ultimate Concepts Inc.

September 17, Keeler Instruments Inc. Mr. Eugene R. Van Arsdale Marketing Manager 459 Parkway Broomall, PA 19008

JUN 2 6 butt. EkoSonicTM Endovascular System with Rapid Pulse Modulation

SECTION 5 BARDEX TEMPERATURE-SENSING FOLEY CATHETER 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS INFORMATION

510(k) SUMMARY MANI Needle and Suture Pack MANI, Inc.

AW Server 510 (k) Summary of Safety and Effectiveness

Dear Ms. Lucas: This letter corrects our substantially equivalent letter of February 18, 2016.

510(k) Summary GlobalMedia Group, LIC. MAY CONiM

EM GR.OUF DIPLOMAT. OT39?1 Company Name: (K)SUMMARY Oc. Submission Correspondent. Emergo Group, Inc. Company Address:

May 20, Ivoclar Vivadent Ag Ms. Donna Hartnett Director Regulatory Affairs Ivoclar Vivadent, Inc. 175 Pineview Drive Amherst, New York 14228

,11 DSA Cable, transducer and VS3, VS4 electrode, patient connector

SUMMARY OF SAFETY AND EFFECTIVENESS for Powered Muscle Stimulator

MAY SECTION VIII. 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS

Building 6, Suite 300 RyeBrook, NY C-ontact-N~ame: --- William H-. Schofield Director of TeleHealth Operations. Signal,_Radiofrequency

51O(K) SUMMARY: Therapy family of devices.

D I Z1. 510(k) Summary. Section 5. Siemens Medical Solutions USA, Inc. Oncology Care Systems. Date Prepared: September 09,

Ni Hau Industrial Co., Ltd. Ms. Lyn Chiu Sales Manager No. 15, Alley 125, Lane 318, Section 2, An Ho Road Tainan City, Taiwan 70967

Dental Morelli Ltda.

March 31, Etiometry, Inc. Richard Galgon Independent Consulting Associate Quintiles 5846 Cobblestone Lane Waunakee, Wisconsin 53597

510(K) SUMMARY. 510(k) Number KOS'00-r

Datrix, Inc NOV Appendix G. 510(k) Summary of Safety and Effectiveness for Datrix, Inc CardioServer ECG Management System

DEC The three components of the Axxent Electronic Brachytherapy System include the Controller, Balloon Applicators-BR and X-ray Source.

July 21, Dentca, Inc. c/o Mr. Claude Berthoin Denterprise International, Inc. 110 East Granada Blvd, Suite 207 Ormond Beach, Florida 32176

Koqo8 go. ER35 ERO-SCAN Pro Hearing Test System. 61 Martin Lane Elk Grove Village, IL Manager of Instrumentation Products

J UN (k) SUMMARY AS REQUIRED BY SECTION (C) Mrs. Mitsuko Yoneyama President. Submitted by:

L~l t l V~! MAY ?

510(k) SUMMARY APR Date: 15 th December 2008

MViAKIO. V.A hn2 ATTACHMENT I 610(K) SUMMARY. Submitter:

ItP. Section I. 510(k) Summary of Safety and Effectiveness. Applicant:

Manufacturing Technology, Inc.

510(k) SUMMARY JUL Otoharmonics 0 Levo 9 System

510(k) Summary of Safety and Effectiveness JUN Hip prosthesis

DEC V,(9/azO (c 0 j

KIZ 2,33-3 p8 ~ 510(k) Summary. As required by 21 CFR (c) 510(k) Premarket Notification Submission AFrame Digital MobileCare Monitor.

510(k) Summary (c)

ATLANTIS Anterior Cervical Plate System ATLANTIS Translational Plate. 510(k) Summary. February 2007

March 23, Vision Quest Industries, Inc. Mr. Mohammed Ouerghi Director of QA/RA 1390 Decision Street, Suite A Vista, CA 92081

sbchoi~kku.edu jeremy~sooil.com DANA Diabecare IlS Insulin Infusion pump Infusion pump Class II

510(k) SUMMARY. OPTION-vyM Urinary Catheter

AgaMatrucx. NV2 21 Salem, NH oz (k) Sumnmary

IQ Corporation c/o Harold G. Haines, Ph.D. President SEP 1 f 2002 South Florida BioAssociates, Inc SW 127h Street Miami, Florida

JN (k) Summary Device Identification: Device Description:

RAMSOFT BUG ,-. I"-, --I 2 N Tel: (416) Fax: (416) sales@ramsoftbiz (k) Summary

foq8 510(k) Summary fo r PAIRIETEX ~ COMPOSITE Mesh

510(K) Summary K102148

OCT 18 20U5Ibko. a. Submitter Name: Cosmetic Dental Materials Inc. (CDM Inc.) b. Submitter Address: 812 Water St. NE Albany OR 97321

Fresenius Medical Care

W~c f-t. MAR 2 1 2fl09SC. 5 10(k) summary TRACTION MASTERS, INC. Traction Masters, Inc. AKA: Spinetronics, LLC 9737 NW 65 PL Parkland, Florida 33076

MAR (k) SUMMARY OF SAFETY AND EFFECTIVENESS (21CFR ) 1. DATE PREPARED: 4/21/2008

MAY Attachment (k) Summary 21 CER

Summary of Safety and Effectiveness

I C 5 5l v ri 510(K) SUMMARY. Prowess Panther

Medical Devices; Cardiovascular Devices; Classification of the Esophageal Thermal Regulation

Section (K) Summary. Kimberly-Clark Corporation Winchester Road Neenah, WI 54956

510(k) Summary SUBMITTER'S NAME, ADDRESS, TELEPHONE NUMBER, CONTACT PERSON, AND DATE SUMMARY PREPARED:

ELASTO-GEL MANIJKAH"O"NEY JUUjj 2. fudbthsarltvl of the wound fluid, while re~leas'ing

Food and Drug Administration 5 10(k) Notijfication - Partial & Total Ossicular Replacement Prostheses AUG I June 30, 2006

r5 73~ 9/ / 510(K) Summary (K) SUMMARY

Histoacryl Flexible Topical Skin Adhesive April15, 2013

510(k) Summary. (508) X222 Disposable Insulin Delivery Device

Transcription:

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 May 22, 2015 Rachel s Remedies, LLC Mrs. Rachel E. Jackson 2316 Delaware Ave. #174 Buffalo, New York 14216 Re: K150139 Trade Name: Rachel s Remedy Regulation Number: 21 CFR 890.5730 Regulation Name: Moist heat pack Regulatory Class: Class I Product Code: IMA, IMD Dated: April 16, 2015 Received: April 22, 2015 Dear Mrs. Jackson: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA s issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act s requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set

Page 2 of 2 Mrs. Rachel E. Jackson forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/medicaldevices/resourcesforyou/industry/default.htm. Also, please note the regulation entitled, Misbranding by reference to premarket notification (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/medicaldevices/safety/reportaproblem/default.htm for the CDRH s Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/medicaldevices/resourcesforyou/industry/default.htm. Sincerely yours, for Felipe Aguel -S Carlos L. Peña, PhD, MS Director Division of Neurological and Physical Medicine Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure

510(k) Summary Prepared on May 19, 2015 Trade Name: Rachel s Remedy Contact Person: Rachel E. Jackson Title: President Address: 542 Parkside Avenue, Buffalo, New York 14216 Phone: 716-362-0237 Fax: 716-362-0246 Email: rachel@rachelsremedy.com Establishment Registration: Submitting within 30 days of 510(k) submission Regulation Number: Classification 890.5730 Device Class: I Common Name, Device: Moist Heat Pack Product Code: IMA Regulation Medical Specialty: Physical Medicine Review Panel: Physical Medicine Intended Use: Rachel's Remedy is designed to provide moist heat and/or cooling relief to relieve symptoms associated with clogged ducts, mastitis, milk blisters, blebs and engorgement. It is also designed to encourage let down and milk flow, and can help to prevent mastitis. Description of Device: Rachel s Remedy is a hot/cold therapy pack composed of a 100% cotton flannel pillow filled with all natural flaxseed. It is designed to provide heating or cooling relief to soothe breastfeeding pain and discomfort. The pillow is inserted into a food-safe water-resistant pouch. There is a removable 100% organic cotton layer that may be moistened and used for moist heat, or the therapy pack may be used alone for heating and/or cooling relief. The flaxseed filled pillow can either be microwaved for heating relief, or put in the freezer for cooling relief. Rachel s Remedy is made from materials manufactured in the United States. The removable cotton layer is 100% organic cotton, the pouch is CPSIA certified and foodsafe PUL, and the flaxseed filled pillow is made from 100% cotton flannel and is filled with 100% all natural flaxseed. All of the fabrics used in Rachel s Remedy are made in the United States and are CPSIA certified and made specifically for baby products.

Predicate Device: The following is a substantially equivalent device that is a legally marketed moist heat pack. Since our indications for use exceed this, we have submitted valid scientific evidence to support and verify our indications for use. 510(K) Number Device Name Applicant Regulation Number Product Code Decision Date Decision Regulation Medical Specialty K832803 Steam Pak Moist Heat Electro Med Health Industries, Inc. 890.5730 IMA 8/18/83 SE PM K841698 Heat Pack Maddak, Inc. 890.5730 IMA 5/10/84 SE PM Equivalency of Technology The Steam Pak Moist Heat device provides moist heat to localized areas of the body and gives approximately 30 minutes of moist heat. It contains a cotton fabric on the outside, and uses gel beads as the heating element. Rachel s Remedy also contains cotton fabric that touches the skin, but contains an all-natural flaxseed filled center as the heating element. Rachel s Remedy provides approximately 20 minutes of moist heat. The difference of the heating element between Rachel s Remedy and the Steam Pak, do not adversely affect the safety or effectiveness of the product. Both products get heated in the microwave, and have the capacity to absorb and release heat over a period of time when placed on the body. Both products use passive heat. Rachel s Remedy could potentially lose heat slightly more quickly, however the user can put it back in the microwave to heat it and reuse it if needed for a longer period of time. Safety The flaxseed pillow is made of 100% cotton flannel, and all materials are made in the United States. The pouch that holds the flaxseed pillow is made of CPSIA certified and food safe fabric which is food grade and certified safe for babies. It is commonly used for bibs, diapers and other baby products. Rachel s Remedy contains a removable 100% organic cotton layer that can be moistened and attached to the pouch to provide moist heat. All of the fabrics used in Rachel s Remedy are made in the United States and are specifically designed for baby products. The only part of Rachel s Remedy that would touch a breastfeeding mother s skin, is the organic cotton. There are no residues or chemicals on either of these fabrics. These fabrics pose no health risks to a nursing infant and an adult woman using Rachel s Remedy.

Performance Data: The following peer-reviewed literature, studies and online reference materials were submitted to support each of the indications for use for Rachel s Remedy as follows: (please see the detailed discussion as to the relevancy of each article to each indication of use which was previously submitted): 1. Let Down and Milk Flow: The following are references to articles and summaries we previously submitted that support use of warm compress applications (like Rachel s Remedy) as a well-recognized method to help with let-down and increase milk flow: See: Resmy V (2014, 620); St. Lukes, F-2, F-3, F- 16; Neifert 91986, 750, 756); Giugliani (2004, 2); Articles were also previously submitted from the American Academy of Pediatrics, La Leche League International and the Nursing Mothers Counsel that recommend moist heat compress applications to improve milk flow and let down. 2. Clogged Milk Ducts, Milk Blisters and Blebs: The following are references to articles and summaries we previously submitted that support use of moist heat applications (like Rachel s Remedy) before each feeding and between feedings to release a clogged/plugged duct, milk blister and bleb: Heller (2012, 1151); Walker, (2008, 269); ANJ (2009, 32); Spencer (2008, 729); Giugliani (2004, 6); Strong (2011, 783). Articles were also previously submitted from the Centers for Disease Control, the American Academy of Pediatrics, the La Leche League International, and the St. Luke s Hospital online Mother-Baby Resource Guide that recommend the use of moist heat to treat Clogged Milk Ducts. 3. Mastitis: The following are references to articles and summaries we previously submitted that support use of warm compresses (like Rachel s Remedy) to relieve symptoms of and to help prevent mastitis: Spencer (2008, 727-729); Heller (2012, 1151); Walker (2008, 721): Niefert (1986, 756-757); Foxman (2002, 105-106 113); Strong (2011, 757, 762, 783). Articles were also previously submitted from the Centers for Disease Control, the American Academy of Pediatrics, the La Leche League International, and the St. Luke s Hospital online Mother-Baby Resource guide, that recommend the use of moist heat on the breast several times per day to treat and prevent mastitis. 4. Engorgement: The following are references to articles and summaries we previously submitted that support the use of warm compresses (like Rachel s Remedy) to the breast before nursing and cool compresses (like Rachel s Remedy) applied to the breasts between feedings to relieve engorgement: Neifert (1986, 750); Strong (2011, 758); Giugliani (2004, 2), Articles were also previously submitted from the Centers for Disease Control, the American Academy of Pediatrics, the La Leche League International, and the St. Luke s Hospital online Mother-Baby Resource guide that recommend warm compresses to the breast before nursing and cool compresses between feedings to relieve engorgement. We have tested Rachel s Remedy s heat retention by doing performance testing by placing Rachel s Remedy in the microwave, putting it in it s waterproof pouch and placing it on the body with and without moistening the removable cotton layer. Rachel s Remedy consistently maintains its warm temperature for a minimum of 20-minute intervals. Conclusion The above summary of nonclinical and clinical information included in this submission support the conclusion that this device is as safe and effective and performs as well as the predicate device.